Today: 18 July 2026
Lynas Rare Earths share price drops today: what ASX investors watch before results
23 February 2026
1 min read

Lynas Rare Earths share price drops today: what ASX investors watch before results

Sydney, Feb 23, 2026, 18:15 AEDT — The market has closed.

  • Lynas Rare Earths slipped 1.5% on Monday, lagging the broader market.
  • With Lynas’ half-year results expected later this week, investors are already making their moves.
  • NdPr, a key rare-earth for magnets, still drives pricing volatility.

Lynas Rare Earths Limited closed Monday at A$15.445, slipping 1.5%. Shares moved in a range from A$15.43 up to A$15.73 during the session.

The retreat comes just ahead of Lynas releasing its half-year numbers for the period ending Dec. 31, 2025. An investor call is set for the same day.

Why it matters now: shares have swung around this month, and a packed earnings slate leaves little room for disappointment—whether that’s on price realisations, volumes, or costs. Global trade news keeps nerves frayed among mining stocks, with sentiment prone to sharp turns.

The S&P/ASX 200 finished Monday’s session 0.61% lower, pressured by fresh worries over U.S. tariffs that dampened risk sentiment, Market Index reported.

Rare-earth prices remain the key swing factor for Lynas. NdPr, or neodymium and praseodymium, essential for permanent magnets in electric vehicles and wind turbines, has surged in recent months and fueled optimism ahead of results season.

Neha Mukherjee, research manager for rare earths at Benchmark Mineral Intelligence, told Reuters last week that “the price rally has been driven by firm downstream magnet demand and deliberate supply management in China.” She also flagged the possibility that the surge might not last. https://www.reuters.com/business/energy/ra…

On the demand front, headlines have remained positive. Japan’s Sojitz plans to boost rare-earth imports from Lynas and will start bringing in samarium from April, aiming to reduce reliance on China.

Lynas hasn’t put out any new ASX statements since February 19, when a substantial-holder notice was lodged, exchange records show.

Next up: the numbers, and any clues about ramping up, product mix shifts, or contract price moves. Traders are also watching for remarks on heavy rare earths—a space where Western supply is sparse and price jumps aren’t rare.

Still, the downside’s hard to ignore. Should NdPr prices slump — a possibility Benchmark’s Mukherjee highlighted, warning of a potential correction by end-March — miners could see margins hit almost immediately, making guidance tougher to pin down.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • DOG Mode Stirs Controversy in Bitcoin Block Space Governance
    July 18, 2026, 4:13 PM EDT. Debate intensifies over Bitcoin governance as DOG Mode disputes the established BIP-110 framework, which regards Bitcoin block space as a limited public utility intended mainly for settlement of monetary transactions. DOG Mode supporters push for a more neutral market model, supporting inclusion of all valid transactions-including large data Ordinals inscriptions-based solely on transaction fees. This proposed change risks fragmenting Bitcoin's network mempool, since different node policies could lead to relaying divergent sets of transactions. Although transaction validity consensus remains in place, this split may affect transaction speeds and how fees are estimated. DOG Mode brings to the foreground the ongoing tension between reserving Bitcoin for financial use and expanding its applications, pointing to a possible protocol governance clash ahead.
Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week
Previous Story

Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop